The researchers highlight that feasibility studies looking at cathepsins as diagnostic tools have shown promising results in the use of cathepsins S and L, and the endogenous inhibitor cystatin C as biomarkers for determining coronary artery disease and the formation of aneurysms. Here, CTSS is linked to aneurysm.